Evaluating the Safety and Immunogenicity of Polyvalent DNA/gp120 HIV Vaccine in Healthy, HIV-uninfected Adults

The requested reference [c9804f613a37778dc50fd8b73d99110f4a7e7206] no longer exists in our database. It has been replaced by the current reference: [28847d99c74d27bddc19cd39cd8978c59458d2b7]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The purpose of the study is to evaluate the safety, tolerability, and immunogenicity of polyvalent env (A,B,C,A/E)/gag (C) DNA and gp120 (A,B,C,A/E) protein vaccines (PDPHV201401) co-administered together with or without adjuvant in repeated doses in healthy, HIV-uninfected adults
Epistemonikos ID: feec1eb5b268c1ed8fe64e5ce5f42b5218d8be3c
First added on: May 09, 2024